Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Friday, 27 May 2022, 10:00 HKT/SGT
Share:
    

Source: Legend Capital
Legend Capital's Portfolio Company Feima Robotics Assists China's 38th Antarctic Expedition with a Series of Civilian UAV Products

HONG KONG, May 27, 2022 - (ACN Newswire) - On April 26, 2022, the expedition ship Xuelong 2 for China's 38th Antarctic expedition berthed at the Shanghai base dock. So far, China's 38th Antarctic expedition, which lasted 174 days and traveled more than 33,000 nautical miles, has ended successfully.

Expedition Ship Xuelong 2 (Image Source: Feima Robotics)

V10 is taking off in Antarctica (Image Source: Feima Robotics)

D2000 Antarctic aerial photography operation (Image Source: Feima Robotics)

V1000 in preparation for takeoff (Image Source: Feima Robotics)

V100 in preparation for takeoff (Image Source: Feima Robotics)

For the 38th Antarctic expedition, the Polar Surveying and Mapping Engineering Center of Heilongjiang Surveying and Mapping Geographic Information Bureau, the School of Surveying and Mapping of Sun Yat-sen University, and the Third Institute of the Ministry of Natural Resources both chose drones from Feima Robotics, a civilian UAV manufacturer in China, to assist in polar aerial photogrammetry. According to media reports, the 38th Antarctic expedition successfully completed the tasks of material supply and personnel rotation at the Great Wall Station and Zhongshan Station in Antarctica and achieved many scientific research results.

Since the 33rd Antarctic expedition in 2016, the civilian UAV intelligent aerial survey remote sensing system series from Feima Robotics has successfully assisted China's 33rd, 34th, 36th, and 38th Antarctic expeditions. Different from the previous three Antarctic expeditions, Feima civilian UAV took over the honored F-series civilian UAV in the 38th expedition, and dispatched V10, D2000, V1000, V100 and other civilian models currently in mainstream service, becoming the only civilian UAV manufacturer in China that has a full range of civilian UAV products to serve polar scientific expeditions and has successfully obtained large-scale effective aerial photography results. As of the completion of the 38th Antarctic expedition in 2022, the Feima civilian UAV has completed nearly 150 total historical and effective flights over the polar regions of the South and North Pole, achieving a veritable "Feima Antarctic Era".

Feima Robotics was founded in 2015 and is a company with more than 15 years of extensive experience in the civilian drone industry. Legend Capital is the very early-stage investor of Feima Robotics as Legend Capital led the Feima Robotics' Series A financing round in June 2016 and has long supported the company's development. Since the establishment of Legend Capital in 2001, it has been systematically investing in the field of science and technology, including new generation display materials, IoT, autonomous driving, AI pharmaceuticals, etc. At present, the investment portfolio has reached more than 100 companies. Legend Capital's technology investments closely follow the national industrial planning and policy guidance and majorly focus on cutting-edge technology fields.



Topic: Press release summary
Source: Legend Capital

Sectors: Trade Shows, PE, VC & Alternatives, Drones
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Legend Capital
Dec 19, 2023 15:45 HKT/SGT
Legend Capital Portfolio Company ZKH Lists on the New York Stock Exchange Successfully
Oct 10, 2023 13:55 HKT/SGT
Co-led by Legend Capital, Leadrive Completes Series D Financing Round
Sept 27, 2023 15:19 HKT/SGT
Legend Capital Portfolio Company TUHU Car Lists on the Main Board of the HKEX Successfully
Aug 18, 2023 20:09 HKT/SGT
Legend Capital Portfolio: Nuclei, the World's First RISC-V CPU IP Vendor, Accomplishes ISO 26262 ASIL-D Product Certificate
Aug 18, 2023 16:43 HKT/SGT
Backed by Legend Capital, the Chinese Pet Food Industry Leader Gambol Pet Goes Public Successfully
July 31, 2023 19:48 HKT/SGT
Exploring New Collaborative Opportunities! The Indonesia-China Healthcare and Biotech Investment Forum Successfully Held
July 14, 2023 16:17 HKT/SGT
One More IPO of Legend Capital: Medical Device Supply Chain Service Provider GKHT Medical Goes Public Successfully
May 4, 2023 16:15 HKT/SGT
Empowering R&D in Special Diseases, "Next Generation" CRO Company TriApex Completes Series C with Hundreds of Millions of CNY, Led by Legend Capital
Mar 31, 2023 09:28 HKT/SGT
Rxilient Biotech and Junshi Biosciences form Joint Venture to develop and commercialize Toripalimab in Southeast Asia
Feb 16, 2023 17:09 HKT/SGT
Led by Legend Capital, Macrolux Completes Nearly CNY100 million Series A Round
More news >>
 News Alerts
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: